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I feel very privileged to be invited 
to be your Stoneburner Lecturer for 
this year. When I came to consider 
what I really wanted to say and what 
might interest people in widely differ-
ent areas of medicine, there really 
was little choice. I perhaps can claim 
to be able to talk about emphysema 
from a rather broader standpoint than 
some other physicians. Not because I 
suffer from it, which is sometimes a 
good reason for talking about a dis-
ease, but because I have been trained 
both in England and in America, and 
the outlook on this disease has differed 
in Europe and in the States. 
I started work on emphysema under 
the guidance of Dr. Christie in 1948, 
and in 1948 no one was much inter-
ested in the disease. I worked in Phila-
delphia in 1952, and there I gave a 
lecture on emphysema which was so 
controversial that it was disbelieved. 
The climate is different now, and I 
am talking about something of which 
most of you already know a fair 
amount. I have selected it as a topic 
because, whether you are a public 
health administrator, an internist, an 
allergist, an anesthetist, a surgeon, or 
even just a cigarette smoker, you 
should be interested in this condition. 
One reason for contemporary con-
cern about this disease is the consider-
able increase in the standardized mor-
tality in the United States since 1945, 
for what physicians call on the death 
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certificate "emphysema and fibrosis." 
The rate of increase of lung cancer 
has been similar, but since 1955 the 
diseases categorized as "emphysema" 
have been increasing more rapidly 
than has lung cancer. Over the same 
period, of course, mortality from tu-
berculosis has dipped. But the puzzle 
of nomenclature can be seen from 
the fact that bronchitis, as certified in 
the United States, has apparently not 
increased at all as a cause of mortality. 
If I were to show you a comparable 
graph from Europe, bronchitis would 
appear to have been the main cause 
of the increased mortality, and emphy-
sema to a much smaller extent. I 
think we now realize that this is purely 
a semantic matter. Differences are 
not great between different industrial-
ized communities in any of these dis-
eases. It has been largely a matter of 
what the physician has called the 
condition he has looked at. 
Certified causes of death at best 
are enigmatic and subject to shifting 
classification. The autopsy incidence 
of morphological emphysema as found 
in 138 random autopsies of inflated 
right lungs at the Massachusetts Gen-
eral Hospital in Boston has been re-
ported by Dr. Thurlbeck. With refer-
ence to men only, and by dividing the 
autopsy population into 12 decades 
of age, the incidence of quite obvious 
morphological emphysema, excluding 
the little bits of emphysema at the 
apices and other minor forms, is strik-
ing. Once men are in the fifth and 
sixth decades, half of the random au-
top•y populotion •how• oon•i\ ob1' 
morphological emphysema. The same 
data in identical form are found in my 
own hospital in Montreal. So Montreal 
and Boston have a virtually identical 
autopsy incidence. Many pathologists 
have emphasized that the true inci-
dence of emphysema can only be eval-
uated if the lungs are inflated. If they 
are fixed when collapsed, he will un-
derestimate the incidence of this con-
dition by at least half; and second, he 
will not be in a position to see, as I 
will show you in a few moments, its 
most damaging form. When the Mas-
sachusetts General Hospital group is 
broken down into categories, the male-
fem ale incidence is very different. 
In 59 females, 45 had no detectable 
morphological emphysema. In 79 
males, only 25 had no emphysema. 
This reflects the 4: 1 prevalence of 
emphysema in men. 
There is another reason why this 
group of diseases has become very im-
portant. You will recall the major epi-
sode of smog in London in 1952, but 
you may have forgotten that this epi-
sode killed 4,000 people in 6 days. The 
smog lasted from December 2 until 
14, approximately. London is so large 
that it took the Registrar General's 
figures 3 weeks to catch up on the 
surplus mortality of 4,000 people. So 
this is another reason why this disease 
has become important. 
The First Challenge 
The first of emphysema's three chal-
lenges is to understand not what the 
acute episode can do, which we know 
very well in a population with some 
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lung disease, but to understand what 
lesser degrees of atmospheric pollution 
do, not over 6 days but over 20 years. 
I fancy it will be a long time before 
we understand the interrelationship 
between the acute sensational phe-
nomenon and the chronic unsensa-
tional mortality. 
I grew up in an era when chronic 
bronchitis did not have a respectable 
pathology. In Boyd's Pathology for 
1947, chronic bronchitis was not a re-
spectable disease. It was mainly an 
important complication of tuberculo-
sis, or it was sometimes a nuisance in 
people with heart disease, but as a 
primary pathological entity it was 
little regarded. It is worth reminding 
you that now it has a highly respect-
able and extremely carefully quanti-
fied pathological existence, depending 
on hypertrophy of the bronchial mu-
cous glands. 
Now it is time we took up some 
practical examples of the kind of pa-
tient you deal with, and we deal with. 
I am not going out of my way to 
speak of the only case I have seen in 
5 years that represented so and such. 
I am talking about things that I be-
lieve are extremely common. The first 
patient was a 66-year-old man who 
worked all his life with the Canadian 
Pacific Railway, largely an office job, 
and gave a rather clear history of 
some breath shortness for 2 years, 
some chronic cough for perhaps 15 
years, not very much sputum, and an 
occasional episode of respiratory in-
fection. He had dyspnea for 1 year. 
The function tests were done when he 
had one such episode while in another 
hospital. He had left that hospital diag-
nosed as having arteriosclerotic heart 
disease. They found an abnormal EKG, 
swollen ankles, liver two fingers-
breadth's enlarged, and a normal chest 
film. When he was studied in the func-
tion lab in November, 1958, the find-
ings were: a vital capacity about half of 
what it should be, a lung volume much 
bigger than it ought to be-gross over-
inflation, and markedly uneven gas dis-
tribution. The F.E.V. (forced expira-
tory volume) should have been 70 L per 
minute, but was only 19 L per minute. 
His airflow rate should have been 3 L 
per second, but was only 0.2 L per 
second; therefore, he had terrible ven-
tilatory obstruction. The transport of 
carbon monoxide, or the diffusing ca-
pacity, should have been about 14 and 
was 7 ml per minute per mm of Hg. 
This tells us either he had very un-
even ventilation/ perfusion distribution 
in the lung, which is commonly found , 
or he had a reduced surface area for 
gas exchange, or a thickened alveolar 
membrane. His arterial C02 tension 
was 56 mm of Hg, and the pH 7.4. You 
know, therefore, this was a chronic sit-
uation because he had brought his bi-
carbonate up to adjust the pH. The 
oxygen saturation was a little down. 
About 9 months after these tests were 
done he came to the hospital with a 
very severe pneumonia, and he died 
as a tracheotomy was being done. The 
whole lung section of this man show,ed 
black areas which look at a distance 
like currants. These are holes which 
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FIG. I-Whole lung section from patient 
with centrilobular emphysema. Barium 
added for clearer demarcation. 
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go from the bottom to the top. They 
can be better shown if you outline the 
normal lung with barium (fig. 1). You 
are now close to what killed him, an 
example of severe widespread centri-
lobular emphysema. Each of these 
holes is roughly in the center of the 
lobule, and around it is an area of re-
maining normal alveoli. Virtually no 
lobule anywhere in either lung is 
spared. When this lung was allowed to 
collapse and sectioned in the normal 
way, it was reported as being normal. 
This lesion is exceedingly hard to see if 
you allow the lung to collapse. When 
these holes collapse, they approximate; 
the alveoli in between are normal, and 
the pathologist, by allowing the lung 
to collapse, has put himself in the 
worst possible position to see the le-
sion responsible for the disease. It was 
Gough in Cardiff who separated out 
this form of emphysema from others. 
He called it centrilobular emphysema. 
It is a good name and it was the first 
step forward in differentiating the pa-
thology of this disease. One of the 
mysteries of emphysema is why this 
is such a lethal condition. The man I 
showed you had normal coronary ar-
teries. His right ventricle was hyper-
trophied and not his left. (He had no 
arteriosclerotic heart disease although 
this had been diagnosed.) The only 
thing he died of was his severe CO, 
retention, which came upon him when 
he got pneumonia. However, he had 
had hypercapnia chronically for sev-
eral years. The mystery is why this le-
sion, which can be quite minimal and 
unspectacular, so often gives rise to 
such severe blood gas disturbance. 
The Second Challenge 
This brings me to challenge number 
two; that is, to understand much more 
fully than we do at the moment the 
interrelationship between the struc-
tural changes, which the pathologist 
can picture, and the functional de-
rangement responsible for the patient 
getting to the pathologist at all. This 
is something which many people are 
working on, and I can only present 
you with the problem and stimulate 
you to this extent: that there probably 
is no disease of an organ as big as the 
lung in which 75 % of the alveoli can 
be intact, and yet in which you die 
from its consequences. There must be 
something then about the situation of 
this lesion in the middle of the lobule 
at the end of the bronchiole which is 
particularly harmful. It is remarkable 
that you cannot get along with 25% 
of your lung gone, if it happens that 
this destruction has occurred at the 
end of each terminal bronchiole. 
There was a period in which people 
used to chat about the tremendous re-
serve of the lung. They said you could 
take one lung out of a man and he 
could walk upstairs. That is fine . He 
can, but you punch out the center of 
each lobule and he has a very limited 
prognosis. 
My second example is of a man 
about the same age as the previous 
man, to illustrate the clues you can 
get in life that the lesion is centrilobu-
lar emphysema. This man's pulmonary 
function tests were similar to those of 
the first patient, also showing severe 
ventilatory defect and hypercapnia 
(table 1). This man happens to still be 
alive. But I wanted to mention him 
because of his chest x-rays (fig. 2a). 
In the close-up of a carefully taken 
bronchogram, where plenty of time 
was allowed for the material to get 
into the pools, the major bronchi are 
fairly normal, but when it gets to the 
periphery it fills the pools. Simon and 
Reid have called these the "Lily of the 
Valley" sign, as the total picture is 
rather like a lily of the valley (fig. 2b ). 
If you will take a lung with centri-
lobular emphysema and inject it in 
the autopsy room, you get a very simi-
lar picture. There is a hole, and fur-
thermore there is considerable distor-
tion of bronchi. The pool is filled at 
the end. So you can get a clue from 
bronchography. As I will show you in 
a moment, there is quite a different 
sort of emphysema which clinically 
may be almost indistinguishable from 
this one. 
I am not going to talk in this lec-
ture about details of technique of 
study, because these are of interest 
only to people working in this field. I 
am going to take a jump, however, to 
describe briefly a technique, because I 
want to show you what you may learn 
with it. I am not going into great de-
tail. The point I want you to get is 
the result. The research group with 
whom I work has been busy for 4 
years working on what may be learned 
by studying how the lung handles ra-
dioactive xenon. Xenon is a radioac-
tive gas that you can breathe in very 
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safely, and measure from outside the 
chest what the lung is doing with it 
(fig. 3). A subject having such a study 
has behind him six scintillation count-
ers, positioned in particular places in 
relation to the chest x-ray, three on 
one side and three on the other. With 
this method, you can get an idea of 
what each bit of the lung is doing; 
sometimes, as I will show you, with 
very surprising results. Then you can 
use it another way. You can dissolve 
xenon in saline and put it in the arm 
vein, and watch its clearance into lung 
alveoli. Of what gets to an alveolus, 
95% will be cleared into the gas phase. 
I think it is quite obvious, without a 
lot of mathematics, that in this way 
you can quantify the ventilation which 
each lung zone is getting, and its 
blood distribution, as shown by this 
study. A complete examination of the 
kind I have very briefly described 
gives you rather less than one-half the 
radiation of a single chest film, so 
there is no serious radiation hazard in 
the use of this particular isotope. 
Now I am going to show you what 
happens if you do this very simple ex-
periment. It takes a few minutes of 
the patient's time and a lot of instru-
mentation, but you can learn a lot 
from it. Figure 4 shows the three 
counter positions on each side-six 
rings where the counters were posi-
tioned on this patient. The patient is a 
46-year-old woman who had been com-
FIG. 4-Location of xenon counters in 
relation to chest film. 
TABLE 1 
Pulmonary function report of Mr . A. H . M., age 61 , who had minimal sputum for 
IO years (<IO cc per day) and dyspnea on exercise for 5 years. 
Vital capacity . . . . . . .. .. .. . . . 
Functional residual capacity ... . .. . . . .. . 
Mixing efficiency . . . ... . .. . . .. . . .. ...... . 
Forced expiratory volume... . ...... .. . . . . . .. . . . 
Maximum midexpiratory flow rate .. 
Arterial 
pC02 •••• • • • • •.. 
pH . 
HCO'a. 
Resting CO diffusion . 
2 .1 L 
5.4 L 
37% 
19 L/ min 
0.24 L/ sec 
58 mm Hg 
7.4 
34.5 mM/L 
5.3 ml CO/ min X mm Hg 
Fm. 2-Chest x-ray (a) and bronchogram (b) of patient A. H. M. 
Fm. 3-Xenon scintillation counters in position. 
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plaining of breathlessness for 2 years. 
She had never smoked more than two 
cigarettes a day, and she never had any 
sputum, not even enough for a speci-
men. When she became dyspneic, no 
one really would believe her. The 
chest film was thought to be normal; 
physical examination of the heart was 
normal; the electrocardiogram was 
normal, and the blood pressure was 
normal. The only thing was her re-
peated statement that she was short of 
breath. The physical signs of the lungs 
were minimal. I think the only thing 
to make you suspicious was that the 
breath sounds were a little hard to 
hear in someone who was quite thin, 
as she weighed only about 105 pounds ; 
she had lost a bit of weight. She was 
so incapacitated with dyspnea that she 
could cook standing up at the stove 
only with difficulty. Of course, the 
consequence of the combination of 
these findings is that you get referred 
to psychiatry. This she had for 6 
months without noticeable benefits, 
except that her own views on psy-
chiatrists became much better defined 
than they had been in the past! 
Comparing predicted values for a 
woman of this size and age, as we have 
in three series of studies (table 2), you 
can see how consistent the pu!mcnary 
function findings were. Her vital ca-
pacity final!y came down to 900 ml. 
The lung volume initially was not big, 
but became bigger. The total lung 
capacity was about correct. The gas 
distribution was very poor. Her ven-
ti1ation was appalling, maximum mid-
expiratory flow rate, unaffected by 
bronchodilators, very bad indeed. The 
resting diffusing capacity was one-
third normal, and on hyperventilation 
we managed to get a reading of 5.6. 
This told us that something was very 
badly wrong with distribution and gas 
exchange. However, there was no C02 
retention , and the oxygen saturation 
was not strikingly abnormal. This is the 
kind of case one should show all resi-
dents from the start, since the ar-
terial blood can be a bad indicator of 
pulmonary abnormality. You can be in-
capacitated for years and have normal 
arterial blood. It is often misused in 
practice by people who have not had 
enough experience with these diseases 
who place too much reliance on this 
as a test of function. It is very impor-
tant to know it, but it is very impor-
tant not to place too much dependence 
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FIG. 5- Section of right lower lobe from patient L. B., showing panlobular emphysema. 
TABLE 2 
Pulmonary function report of Mrs . L.B., age 46. See Fig. 4 for x-ray. 
Pre- April , May, April, 
dieted 1958 1960 1961 
--- - -- ------
Vital capacity (L) . . . . 2.8 1. 3 1. I 0 .9 
Functional residual capacity (L). .. . 2.6 2.6 3 .1 3.5 
Total lung capacity (L) . 4.2 3.4 3.8 4.1 
Mixing efficiency (3) . 60 : 22 37 17 
Forced expiratory volume0 75 X 40 (indirect max-
imum breathing capacity) (L/ min). 76 13 15 11 
Maximum midexpiratory flow rate (L/ sec) . .. . .. 3.7 0.17 0.20 0. 15 
Resting CO diffusion (ml/ mm Hg X min) . . . . . 14.0 4.6 4.3 4.4 
Arterial blood 
pH . . . . . . . . ' . . . . . . . . . . . . . . . . . . .. . . . 7.4 7.42 7.41 7 .37 
pCO, (mm Hg) . . . . . . . . . . . . . . . . . . . .. . . .. . . 40 40 43 40 
0 2 Hb saturation (3). . . . . . . . ... .. . .. . 94 90 95 91 
TABLE 3 
Xenon133 distribution indices of Mrs. L. B. 
Right Left 
Upper Mid Lower Upper Mid Lower 
Tidal breath . ... . . . . 139 33* 12* 88* 29* 106* 
Predicted. .. . . ... . 58 70 87 57 70 91 
Perfusion . .... . . .. 249 69 61 278 79 86 
Predicted. 38 70 137 42 67 129 
* Abnormally slow clearance observed from these sites. 
on it. I will show you why this wom-
an's arterial blood was normal, be-
cause it is quite clear when you see 
where the ventilation and perfusion 
were going, that they were fairly accu-
rately matched. It is worth stressing 
that you can be in a desperate situation 
from a ventilation point of view for 
years, without any change in the arte-
rial blood. This is another part of the 
challenge of relating structure to func-
tion. 
(Table 3) Now, the xenon technique 
I showed you ends up as a series of 
numbers, and I am not going into the 
derivation of these numbers; we call 
them distribution indices. Their mag-
nitude is not very important, but they 
tell us the amount of ventilation going 
into different portions of one lung and 
the other. What I want you to notice is 
that, on simple tidal breathing, instead 
of there being slightly more ventilation 
in the lower than the upper, on the 
right side there is a 10-fold difference, 
and perfusion distribution on the right 
side is also reduced. Almost all the per-
fusion is going through the upper part 
of the right lung, and much less in the 
lower. As you sit there, upright, which 
is the position she was studied in, you 
have about four times as much perfu-
sion through the lower as the upper, so 
that in normal subjects the upper zone 
counter is about 60, and in her it was 
about 150. There is much better ven-
tilation in the left lower zone. It is 
much better, in fact, than the left 
upper. However, we have the same 
imbalance of blood distribution, so 
that we now know what we never 
would have guessed from the chest 
film, let alone from the stethoscope, 
that the right lower zone has grossly 
impaired ventilation and perfusion. 
Presumably this is one of the main 
areas that has been destroyed. With 
these people who have been almost 
entirely incapacitated for years who 
are below the age of 50, we have on 
occasion taken out lobes that are do-
ing nothing. Figure 5 shows what her 
right lower lobe looked like. This was 
a completely destroyed lobe. It was 
destroyed this time not in the centri-
lobular fashion showed in the first 
patient, but generally destroyed. This 
often is referred to as panacinar or 
pan lobular emphysema. Already, 
therefore, we have made a differentia-
tion. This is a youngish woman with 
very little smoking history, virtually 
no bronchitis, and at least one lobe of 
her lung, and probably the left lower 
as well, has been destroyed. At opera-
tion, the right upper looked normal, 
but I do not believe it was completely 
normal. We got marginal improve-
ment in function by taking out the 
lower lobe. She was just able to go 
out and walk around the block. She 
is still alive. The blood gases are ex-
actly as they always were. To return 
to that point about the blood gases, 
when one lobe, in her case the right 
upper, is getting most of the ventila-
tion and most of the perfusion, there 
is no imbalance. The lung manages to 
keep the arterial blood normal, but 
half the right thorax is occupied by a 
lobe which is idle in terms of ventila-
tion and perfusion. It was because we 
believed then, as we do now, that this 
destroyed lobe in some circumstances 
can interfere with the ventilation of 
the more normal lobe on the same 
side that the lobectomy was per-
formed. 
I wanted to show you a similar 
situation in a man of about the same 
age. If you study chest x-rays and 
tomograms carefully, by looking very 
carefully at the vasculature, you can 
get some idea where the blood is go-
ing. Figure 6 shows the angiogram of 
a patient in whom radioactive xenon 
studies were performed. These showed 
that the left upper zone was getting 
about five-sixths of both ventilation and 
perfusion. It was all he had to live on. 
He had been incapacitated for 4 years. 
The angiogram shows clearly the pre-
dominant perfusion of the left upper 
zone. If the pathological differentiation 
were as clear-cut as I have just made 
it, we would be on very good ground. 
But that isn't so. Often these two le-
sions occur together in the same lung. 
This is a commonplace finding when 
you look at autopsy material. Before 
one gets fancy about differential eti-
ology, it is important to remember 
that whatever theory you construct 
may have to explain the simultaneous 
incidence of the two lesions in the 
same lung. 
One of the points of the radioactive 
xenon technique is to see whether it 
can tell us not only what one lobe, or 
zone, is doing in relation to others, 
which is an interesting thing to know, 
but also whether, by some refinement 
or tr ick, it can tell us anything about 
the distribution of blood and gas oc-
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FIG. 6-Angiogram of patient with pan-
lobular emphysema. The upper lobes are 
relatively spared. 
FIG. 7-Chest film of a young asthmatic. 
X-ray alone could lead to a mistaken di-
agnosis of emphysema. 
curring within a specific zone. Al-
though we have gone only a little way 
with this kind of differentiation, it is 
worth mentioning. We are trying to 
develop means of measuring effective 
ventilation within zones or counter 
fields, in the hope that differences may 
reflect varying pathological types of 
emphysema. We think this may be-
come very important because it seems 
to us that the pattern of centrilobular 
emphysema usually has this kind of 
imbalance. This is the first clue we 
have had in 10 years of work that 
might get us closer to the differential 
function of these different types of 
emphysema. 
The Third Challenge 
Now, my third challenge in em-
physema is, of course, to the clinician. 
It is to challenge him to be able to 
differentiate in life between bronchi-
tis, asthma, and emphysema. It is 
really a challenge to get close to the 
morphology of the lung of the patient 
he is treating. In other words, how 
can he find out what the morphology 
was like, not merely afterward when 
we have the lung to look at, but during 
life? Most physicians would agree that 
this is very difficult. It is very difficult 
in the Jung because the x-rays are, 
with some exceptions, of rather little 
value. The physical examination is al-
most worthless and is as often mis-
leading in terms of differentiation as 
it is helpful. By that I mean, that if 
the chest is barrel-shaped, I still don't 
know what's happening to the Jung 
underneath. Not only do I not know, 
but I know that you don't know, and 
no amount of talking on the chest 
TABLE 4 
contour in relation to lung morphol-
ogy will convince me that you can do 
very well with a tape measure, or 
standing and looking at the plain x-ray 
film. The better pathologists you have, 
the worse you will find you are doing. 
One kind of x-ray is often diagnosed 
in x-ray departments as indicating 
emphysema. The one in figure 7 be-
longs to a radio weather forecaster, 
so that if I listen to the weather fore-
cast in the morning at half-past seven, 
I can hear whether he's wheezing. 
He's a young man of 28. He has a 
clear history of allergy in the family, 
suffers from hay fever, and is an asth-
matic; never very severe but never 
completely free of bronchospasm. The 
plain film could easily deceive a ra-
diologist into thinking this might be 
destroyed lung. On examination in the 
pulmonary laboratory (table 4), he 
had an impaired vital capacity. His 
lung was somewhat over inflated, as 
the residual volume is a 1,300 ml too 
big. The ratio of residual volume to 
total lung volume, which some people 
like to think of as a measure of em-
physema, was elevated. The gas dis-
tribution was poor, the ventilation was 
diminished, and the maximum mid-
expiratory flow rate was quite con-
siderably down. The resting diffusing 
capacity, however, was above normal. 
When you see this phenomenon of a 
normal diffusing capacity by a steady-
state method, you can go out on a 
limb and say you never have that kind 
of diffusing capacity when your lung 
parenchyma is destroyed. That is the 
only way you can really use it. When 
it's like this, regardless of how bad 
the ventilation is, regardless of how 
Pulmonary function report of Mr. F. E., age 28, who had spasmodic asthma. 
Blood gas tensions were normal. Xenon studies: slight prolongation of wash in 
and washout in all zones; normal indices of perfusion and ventilation distribution; 
no disparity between clearance of " ventilated" and " perfused" lung. 
Vital capacity (L) ... 
Functional residual capacity (L) . . .. .. . . . . . 
Residual volume ... . .... . 
Residual volume/ total lung capacity (% ) . . ... . . . .. . 
Mixing efficiency (%) .. . .. .. . . . ........... . 
Forced expiratory volumeo.75 X 40, (indirect maximum 
breathing capacity) (L/ min) . . . 
Maximum rnidexpiratory flow rate (L/ sec) .... . . . . . . . . . 
Resting CO diffusion (ml/ min X mm Hg) .. . 
40 
Predicted Observed 
5.6 3.4 
4.2 3.8 
2.0 3.3 
26 49.5 
65 34 
140 83 
4 .50 1.30 
23. 5 33 .0 
bad the gas distribution is, you'll never 
lose your money if you bet on a nor-
mal parenchyma. Of course such pa-
tients rarely get to pathology, so you 
don't win much because these asth-
matics do not tend to die. But this 
tells you his lung parenchyma must be 
intact, regardless of what the x-ray 
department thinks. When you study 
such a man with a single breath of in-
spired xenon, you find that his re-
gional gas distribution is normal. He 
has no gross change in perfusion dis-
tribution either. But when you study 
him on a steady state experiment, you 
find in this particular man that the 
right upper and lower zones have a 
very considerably impaired ventila-
tion. I show him because I don't know 
why his asthma is not a uniform phe-
nomenon. I don't know why it has 
singled out two zones, but this appears 
to be a common feature in asthmatics. 
It is important to stress that spasmodic 
asthma does not of itself give rise to 
emphysema. They are utterly and 
completely distinct phenomena. In 
terms of xenon distribution, asthma 
does not appear to cause the kind of 
gross upset of perfusion distribution 
you commonly see with a destroyed 
lobe, nor does it cause the imbalance 
between ventilation and perfusion 
clearance you may see in centrilobu-
lar emphysema. What it does cause is 
regional ventilation impairment with-
out much change of perfusion. There 
is an upset of ventilation-perfusion 
distribution, but it is a consequence 
of the ventilation change, the perfu-
sion being very much as normal. 
In this differentiation between em-
physema and asthma, there is one im-
portant bit of evidence I have not 
dwelt on or shown you anything 
about. That is, in emphysema, at a 
certain lung volume, which we'll say 
is 4.5 L, the transpulmonary pres-
sure, or the pressure between the 
esophagus and the mouth, is much less 
negative than in normal people. Asth-
matics, however, whether over or un-
der 20, follow more or less the normal 
curve for lung recoil. If you destroy 
alveoli, you cut down the normal re-
coil of the lung, which is quite a use-
ful way of knowing whether you are 
looking at an asthmatic lung with a 
normal recoil, or whether you're look-
ing at one which has destroyed al-
veoli. This simple test is not used 
anything like enough, and we have 
evidence that it very rarely lets you 
down. 
There must be 15 theories of the eti-
ology in emphysema and you are quite 
entitled to take your pick among 
these. It is probably as good as any-
one else's pick. But that is not really 
the question we can yet ask. We have 
to be sure we are looking at one con-
dition. We have to be sure that we 
have refined our understanding of the 
relationship between the structural 
change, which the pathologists can 
show us, and the function defect, as 
far as we can. Only then can we talk 
meaningfully about differentiations in 
this disease in life. And when the 
practicing physician is faced with a 
man of 45 with a chronic cough and 
a good deal of dyspnea, he is chal-
lenged to predict what the lung is like. 
Until he seriously tries to do this, it's 
extraordinarily hard to realize how 
bad the methods are at his disposal 
to make any differentiation between 
bronchitis with airway obstruction, 
asthma with spasmodic airway ob-
struction, often chronic (both of those 
having an intact lung parenchyma), 
and the differing kinds of emphysema. 
Only if he is worrying about the vas-
cular pattern of the lung, only if, with 
the support of the function Jab, he is 
moving a little closer to excluding 
people from one or another category, 
can he really get a perception in his 
own mind of how good or bad he is 
at making this kind of clinical differ-
entiation. This distinction is not 
merely of academic interest. It is ab-
solutely cardinal in understanding the 
interrelationships of these diseases and 
guessing intelligently at their etiology. 
There is never any excuse for sloppy 
clinical thinking; there is surely every 
reason to encourage people to sharpen 
it to the maximum. The first thing you 
learn when you try to predict accu-
rately the morphology of the lung in 
people, and follow them over a long 
period of time, is that in this main en-
deavor, we have hardly yet begun. 
"It is surprising, perhaps, to re-
alize how many people at one time 
or another exert some sort of medi-
cal function. The old-world grand-
mother who nursed a dozen cases 
of measles in her own children does 
not hesitate to make a diagnosis 
on her young grandchild, nor to 
tell her daughter precisely what to 
do. The arthritic may sing the 
praises of flannel cloths and goose-
fat; the newspaper editor may 
freely recommend a "reducing 
diet," and the pharmacist a sleep-
ing-pill or headache remedy. Lay-
men who give such advice are 
relying on experience. Often the 
advice seems to work, perhaps not 
perfectly, but at least to a gratify-
ing degree. 
"Many laymen have been ex-
tremely skilled in diagnosis and 
have achieved considerable thera-
peutic success. However, giving 
appropriate advice is only part of 
medical skill-an important prac-
tical part, to be sure, but still only 
a part. The layman can learn from 
experience what to do, but the phy-
sician must also know why he does 
what be does. He must know it in a 
manner quite detailed, clear and ra-
tional, organized and logical. It 
is this knowledge which sets off 
the physician from the layman ... 
Aristotle made the distinction quite 
explicit, that almost anyone can 
learn procedure empirically, 
through rule of thumb, but who-
ever lays claim to scientific knowl-
edge must know the reasons and 
the general principles." 
Lester S. King, The Growth 
of M edical Thought. Chi-
cago: The University of 
Chicago Press, 1963, pp. 
1-2. 
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